| Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosis H Yang, E Duchesneau, R Foster, A Guerin, E Ma, NP Thomas Journal of medical economics 20 (10), 1056-1065, 2017 | 36 | 2017 |
| The additional costs per month of progression-free survival and overall survival: An economic model comparing everolimus with cabozantinib, nivolumab, and axitinib for second … E Swallow, A Messali, S Ghate, E McDonald, E Duchesneau, JR Perez Journal of Managed Care & Specialty Pharmacy 24 (4), 335-343, 2018 | 20 | 2018 |
| Cost effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in the United States E Stein, J Xie, E Duchesneau, S Bhattacharyya, U Vudumula, B Ndife, ... Pharmacoeconomics 37, 239-253, 2019 | 15 | 2019 |
| Hepatitis A, B, and A/B vaccination series completion among US adults: a claims-based analysis PK Ghaswalla, BJ Patterson, WY Cheng, E Duchesneau, M Macheca, ... Human Vaccines & Immunotherapeutics 14 (11), 2780-2785, 2018 | 14 | 2018 |
| Real-world persistence with fingolimod for the treatment of multiple sclerosis: a systematic review and meta-analysis D Kantor, K Johnson, MC Vieira, J Signorovitch, N Li, W Gao, V Koo, ... Journal of the Neurological Sciences 388, 168-174, 2018 | 13 | 2018 |
| The timing, the treatment, the question: comparison of epidemiologic approaches to minimize immortal time bias in real-world data using a surgical oncology example ED Duchesneau, BE Jackson, M Webster-Clark, JL Lund, ... Cancer Epidemiology, Biomarkers & Prevention 31 (11), 2079-2086, 2022 | 12 | 2022 |
| Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer SJ An, ED Duchesneau, PD Strassle, K Reeder-Hayes, KK Gallagher, ... NPJ Breast Cancer 8 (1), 65, 2022 | 9 | 2022 |
| A budget impact analysis of the introduction of copanlisib for treatment of relapsed follicular lymphoma in the United States S Appukkuttan, E Duchesneau, ML Zichlin, RH Bhak, A Yaldo, M Gharibo, ... Journal of Managed Care & Specialty Pharmacy 25 (4), 437-446, 2019 | 9 | 2019 |
| Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019 ED Duchesneau, AC Kinlaw, M Jonsson Funk, V Pate, JL Lund Pharmacoepidemiology and drug safety 31 (4), 481-487, 2022 | 7 | 2022 |
| A claims-based analysis of hepatitis A, B and A/B vaccination series completion and compliance among US adults BJ Patterson, WY Cheng, AF Trofa, A Duchesneau, M Macheca, ... Value Health 20 (5), A79, 2017 | 7 | 2017 |
| Higher admission frailty scores predict increased mortality, morbidity, and healthcare utilization in the elderly burn population KA Iles, E Duchesneau, PD Strassle, L Chrisco, TC Howell, B King, ... Journal of Burn Care & Research 43 (2), 315-322, 2022 | 6 | 2022 |
| Increased long-term bleeding complications in females undergoing endovascular revascularization for peripheral arterial disease K Marulanda, E Duchesneau, S Patel, SE Browder, DM Caruso, CB Agala, ... Journal of vascular surgery 76 (4), 1021-1029. e3, 2022 | 5 | 2022 |
| Translation of a Claims-Based Frailty Index From the International Classification of Diseases, Ninth Revision, Clinical Modification to the Tenth Revision ED Duchesneau, S Shmuel, KR Faurot, J Park, A Musty, V Pate, ... American Journal of Epidemiology 192 (12), 2085-2093, 2023 | 4 | 2023 |
| Incidence of venous thromboembolism in patients with peripheral arterial disease after endovascular intervention DG Kindell, K Marulanda, DM Caruso, E Duchesneau, C Agala, M Farber, ... Journal of Vascular Surgery: Venous and Lymphatic Disorders 11 (1), 61-69, 2023 | 4 | 2023 |
| Predictors of overall survival (OS) in veterans with non-metastatic castration resistant prostate cancer (nmCRPC). AD Fuld, Y Young-Xu, S Li, D Pilon, R Bhak, E Duchesneau, M Hellstern, ... Journal of Clinical Oncology 36 (15_suppl), e17057-e17057, 2018 | 4 | 2018 |
| Big data for geriatric oncology research ED Duchesneau, HD Klepin, AD Hanchate, MY Lin, SM Bluethmann North Carolina Medical Journal 85 (1), 2024 | 3 | 2024 |
| Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study ED Duchesneau, AM McNeill, W Schary, V Pate, JL Lund Journal of Geriatric Oncology 14 (8), 101602, 2023 | 3 | 2023 |
| Gender disparities in aortoiliac revascularization in patients with aortoiliac occlusive disease AJ Allen, D Russell, ME Lombardi, ED Duchesneau, CB Agala, ... Annals of vascular surgery 86, 199-209, 2022 | 3 | 2022 |
| Sociodemographic and clinical predictors of neoadjuvant chemotherapy in cT1-T2/N0 HER2-amplified breast cancer ED Duchesneau, SJ An, PD Strassle, KE Reeder-Hayes, KK Gallagher, ... Annals of surgical oncology 29 (5), 3051-3061, 2022 | 3 | 2022 |
| The role of provider characteristics on the hepatitis A and B vaccination status of adults in the United States during 2007–2015 PK Ghaswalla, BJ Patterson, WY Cheng, E Duchesneau, M Macheca, ... Preventive Medicine Reports 14, 100833, 2019 | 3 | 2019 |
